Supplementary Table 1 from A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 1 - PDF file 56K, Spearman Rank Correlation Analysis of Biomarkers for Overall Survival
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361968240